Eastgate Biotech Corp. Stock Analysis ETBI

Eastgate Biotech Corp. engages in the development of novel formulations of natural compounds and pharmaceutical products. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-01-16. The firm utilizes nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all too often create dangerous side effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The company develops products in which active components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles), and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles). Its E-Drops NANO is used to combat urinary and vaginal tract infections. VCleanzz is an antibacterial wash for fruits and vegetables. Cleanezze is a natural hand sanitizer that will not dry or crack skin.